Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test: A placebo-controlled trial

Dermatology

Volumn 212, Issue 2, 2006, Pages 150-159

  Staubach, P ^a   Onnen, K ^a   Vonend, A ^a   Metz, M ^a   Siebenhaar, F ^a,e   Tschentscher, I ^a,b   Opper, B ^a   Magerl, M ^a,e   Ludtke R ^c   Kromminga, A ^d   Maurer, M ^a,e  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c Karl und Veronica Carstens Stiftung   (Germany)

^d Institute for Immunology   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Autohemotherapy; Autoimmune; Autologous serum skin test; Urticaria; Whole blood injection

Indexed keywords

ANTIHISTAMINIC AGENT; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN E RECEPTOR; PLACEBO;

ADULT; ARTICLE; BLOOD AUTOTRANSFUSION; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SKIN TEST; STATISTICAL SIGNIFICANCE; URTICARIA;

ADULT; ANTIBODIES, ANTI-IDIOTYPIC; BLOOD TRANSFUSION, AUTOLOGOUS; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; PATIENT SATISFACTION; PROSPECTIVE STUDIES; QUALITY OF LIFE; RECEPTORS, IGE; SERUM; SINGLE-BLIND METHOD; SKIN TESTS; TREATMENT OUTCOME; URTICARIA;

EID: 32944466021     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090656     Document Type: Article

References (32)

1. Bindslev-Jensen C, Finzi A, Greaves M, Camarasa J, Ortonne JP, Schopf E, Tennstedt D: Chronic urticaria: diagnostic recommendations. J Eur Acad Dermatol Venereol 2000;14: 175-180.
2. Verneuil L, Leconte C, Ballet JJ, Coffin C, Laroche D, Izard JP, Reznik Y, Leroy D: Association between chronic urticaria and thyroid autoimmunity: a prospective study involving 99 patients. Dermatology 2004;208:98-103.
3. Hide M, Francis DM, Grattan CE, Hakimi J, Kochan JP, Greaves MW: Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993;328:1599-1604.
4. Nettis E, Dambra P, D'Oronzio L, Cavallo E, Loria MP, Fanelli M, Ferrannini A, Tursi A: Reactivity to autologous serum skin test and clinical features in chronic idiopathic urticaria. Clin Exp Dermatol 2002;27:29-31.
5. Asero R, Tedeschi A, Lorini M, Salimbeni R, Zanoletti T, Miadonna A: Chronic urticaria: novel clinical and serological aspects. Clin Exp Allergy 2001;31:1105-1110.
6. Niimi N, Francis DM, Kermani F, O'Donnell BF, Hide M, Kobza-Black A, Winkelmann RK, Greaves MW, Barr RM: Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol 1996;106:1001-1006.
7. Piconi S, Trabattoni D, Iemoli E, Fusi ML, Villa ML, Milazzo F, Clerici M: Immune profiles of patients with chronic idiopathic urticaria. Int Arch Allergy Immunol 2002;128: 59-66.
8. Greaves M: Autoimmune urticaria. Clin Rev Allergy Immunol 2002;23:171-183.
9. O'Donnell BF, Barr RM, Black AK, Francis DM, Kermani F, Niimi N, Barlow RJ, Winkelmann RK, Greaves MW: Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol 1998;138:101-106.
10. Grattan CE, Francis DM, Slater NG, Barlow RJ, Greaves MW: Plasmapheresis for severe, unremitting, chronic urticaria. Lancet 1992; 339:1078-1080.
11. Sabroe RA, Seed PT, Francis DM, Barr RM, Black AK, Greaves MW: Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies. J Am Acad Dermatol 1999;40:443-450.
12. Fleck M: Urticaria; in Gottron H, Schönfeld W (eds): Dermatologie und Venerologie. Stuttgart, Thieme, 1959, vol 3, pp 265-298.
13. Illig L: Urtikaria und Quincke-Ödem; in Korting G (ed): Dermatologie in Praxis und Klinik. Stuttgart, Thieme, 1980, vol 2, p 16. 1-30.
14. Keller P: Die Behandlung der Haut- und Geschlechtskrankheiten in der Sprechstunde. Berlin, Springer, 1948.
15. Bocci V: Autohaemotherapy after treatment of blood with ozone. A reappraisal. J Int Med Res 1994;22:131-144.
16. Pittler MH, Armstrong NC, Cox A, Collier PM, Hart A, Ernst E: Randomized, doubleblind, placebo-controlled trial of autologous blood therapy for atopic dermatitis. Br J Dermatol 2003;148:307-313.
17. Olwin JH, Ratajczak HV, House RV: Successful treatment of herpetic infections by autohemotherapy. J Altern Complement Med 1997; 3:155-158.
18. Sabroe RA, Grattan CE, Francis DM, Barr RM, Kobza Black A, Greaves MW: The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 1999;140:446-452.
19. Grattan CE, O'Donnell BF, Francis DM, Niimi N, Barlow RJ, Seed PT, Kobza-Black A, Greaves MW: Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria. Br J Dermatol 2000;143:365-372.
20. Kromminga A, Scheckenbach C, Georgi M, Hagel C, Arndt R, Christophers E, Brocker EB, Zillikens D: Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180. J Autoimmun 2000;15:293-300.
21. Sanger F: Determination of nucleotide sequences in DNA. Science 1981;214:1205-1210.
22. Mori O, Hashimoto T: Autologous whole blood intramuscular injection as a cure for chronic urticaria: report of a patient in whom intradermal injection of autologous serum continued to cause a weal-and-flare response. Br J Dermatol 1999;140:1192-1193.
23. Poon E, Seed PT, Greaves MW, Kobza-Black A: The extent and nature of disability in different urticarial conditions. Br J Dermatol 1999; 140:667-671.
24. Finlay AY, Khan GK: Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210-216.
25. Sabroe RA, Fiebinger E, Francis DM, Maurer D, Seed PT, Grattan CEH, Kobza Black A, Stingl G, Greaves MW, Barr RM: Classification of anti-FceRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J Allergy Clin Immunol 2002;110:492-499.
26. Fagiolo U, Kricek F, Ruf C, Peserico A, Amadori A, Cancian M: Effects of complement inactivation and IgG depletion on skin reactivity to autologous serum in chronic idiopathic urticaria. J Allergy Clin Immunol 2000;106:567-572.
27. Horn MP, Pachlopnik JM, Vogel M, Dahinden M, Wurm F, Stadler BM, Miescher SM: Conditional autoimmunity mediated by human natural anti-Fc(epsilon)RIalpha autoantibodies? FASEB J 2001;15:2268-2274.
28. Miescher SM, Horn MP, Pachlopnik JM, Baldi L, Vogel M, Stadler BM: Natural anti-FcepsilonRIalpha autoantibodies isolated from healthy donors and chronic idiopathic urticaria patients reveal a restricted repertoire and autoreactivity on human basophils. Hum Antibodies 2001;10:119-126.
29. Horn MP, Gerster T, Ochensberger B, Derer T, Kricek F, Jouvin MH, Kinet JP, Tschernig T, Vogel M, Stadler BM, Miescher SM: Human anti-FcepsilonRIalpha autoantibodies isolated from healthy donors cross-react with tetanus toxoid. Eur J Immunol 1999;29:1139-1148.
30. Yang X: Does allergen immunotherapy alter the natural course of allergic disorders? Drugs 2001;61:365-374.
31. Birnbaum G, Weksler ME, Siskind GW: Demonstration of an antibody-mediated tolerance state and its effect on antibody affinity. J Exp Med 1975;141:411-426.
32. Alvarado-Flores E, Avalos-Diaz E, Diaz L, Herrera-Esparza R: Anti-idiotype antibodies neutralize in vivo the blistering effect of pemphigus foliaceus IgG. Scand J Immunol 2001; 53:254-258.